Vineet Laboratories Limited (NSE:VINEETLAB)
India
· Delayed Price · Currency is INR 38.55
+2.11 (5.79%)
Apr 29, 2026, 3:29 PM IST
Vineet Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Cash & Equivalents | - | 3.07 | 2.28 | 6.31 | 166.59 | 21.02 | Upgrade
|
| Cash & Short-Term Investments | 6.55 | 3.07 | 2.28 | 6.31 | 166.59 | 21.02 | Upgrade
|
| Cash Growth | -35.04% | 34.68% | -63.88% | -96.21% | 692.66% | 54584.78% | Upgrade
|
| Accounts Receivable | - | 132.47 | 316.04 | 351.63 | 361.98 | 427.14 | Upgrade
|
| Other Receivables | - | - | 0.59 | 0.3 | - | - | Upgrade
|
| Receivables | - | 132.47 | 316.63 | 351.93 | 361.98 | 427.14 | Upgrade
|
| Inventory | - | 499.71 | 493.94 | 461.74 | 435.4 | 396.86 | Upgrade
|
| Other Current Assets | - | 38.69 | 69.04 | 54.66 | 63.07 | 18.61 | Upgrade
|
| Total Current Assets | - | 673.94 | 881.88 | 874.63 | 1,027 | 863.62 | Upgrade
|
| Property, Plant & Equipment | - | 254.59 | 269.15 | 266.46 | 213.84 | 196.65 | Upgrade
|
| Long-Term Investments | - | 2.06 | 1.82 | 1.34 | 1.36 | 1.18 | Upgrade
|
| Long-Term Accounts Receivable | - | - | - | - | 40.34 | 13.34 | Upgrade
|
| Other Long-Term Assets | - | 14.81 | 15.87 | 16.07 | 50.58 | 12.62 | Upgrade
|
| Total Assets | - | 945.4 | 1,169 | 1,158 | 1,333 | 1,087 | Upgrade
|
| Accounts Payable | - | 336.12 | 322.58 | 348.94 | 600.92 | 559.88 | Upgrade
|
| Accrued Expenses | - | 35.06 | 30.07 | 30.02 | 20.18 | 23.28 | Upgrade
|
| Short-Term Debt | - | 352.75 | 390.94 | 251.98 | 247.92 | 90.07 | Upgrade
|
| Current Portion of Long-Term Debt | - | 9.86 | 13.2 | 10.43 | - | - | Upgrade
|
| Current Income Taxes Payable | - | - | 1.22 | 4.4 | 28.69 | 12.41 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | - | 1.5 | Upgrade
|
| Other Current Liabilities | - | 10.1 | 1.96 | 99.33 | 49.99 | 59.36 | Upgrade
|
| Total Current Liabilities | - | 743.89 | 759.96 | 745.1 | 947.69 | 746.5 | Upgrade
|
| Long-Term Debt | - | 37.86 | 38.86 | 48.48 | 17.22 | 34.66 | Upgrade
|
| Pension & Post-Retirement Benefits | - | 6.42 | 6.31 | 5.88 | 8.74 | 8.47 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 9.13 | 14.59 | 20.54 | 17.91 | 22.68 | Upgrade
|
| Other Long-Term Liabilities | - | 1.62 | 1.76 | 1.67 | 9.42 | 8.97 | Upgrade
|
| Total Liabilities | - | 798.93 | 821.48 | 821.66 | 1,001 | 821.27 | Upgrade
|
| Common Stock | - | 92.19 | 92.19 | 92.19 | 92.19 | 92.19 | Upgrade
|
| Retained Earnings | - | -59.24 | 142.67 | 132.4 | 129.1 | 63.07 | Upgrade
|
| Comprehensive Income & Other | - | 113.52 | 112.38 | 112.24 | 110.9 | 110.9 | Upgrade
|
| Shareholders' Equity | 142.21 | 146.48 | 347.24 | 336.84 | 332.18 | 266.15 | Upgrade
|
| Total Liabilities & Equity | - | 945.4 | 1,169 | 1,158 | 1,333 | 1,087 | Upgrade
|
| Total Debt | 427.81 | 400.47 | 443 | 310.89 | 265.14 | 124.73 | Upgrade
|
| Net Cash (Debt) | -421.27 | -397.4 | -440.72 | -304.58 | -98.54 | -103.71 | Upgrade
|
| Net Cash Per Share | -45.85 | -43.11 | -47.81 | -33.04 | -10.69 | -11.25 | Upgrade
|
| Filing Date Shares Outstanding | 9.25 | 9.22 | 9.22 | 9.22 | 9.22 | 9.22 | Upgrade
|
| Total Common Shares Outstanding | 9.25 | 9.22 | 9.22 | 9.22 | 9.22 | 9.22 | Upgrade
|
| Working Capital | - | -69.95 | 121.92 | 129.53 | 79.36 | 117.12 | Upgrade
|
| Book Value Per Share | 15.25 | 15.89 | 37.67 | 36.54 | 36.03 | 28.87 | Upgrade
|
| Tangible Book Value | 142.21 | 146.48 | 347.24 | 336.84 | 332.18 | 266.15 | Upgrade
|
| Tangible Book Value Per Share | 15.25 | 15.89 | 37.67 | 36.54 | 36.03 | 28.87 | Upgrade
|
| Land | - | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | Upgrade
|
| Buildings | - | 47.7 | 47.7 | 45.95 | - | 43.3 | Upgrade
|
| Machinery | - | 457.93 | 447.48 | 421.35 | 347.66 | 308.89 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.